SCHEMBL1806327

SCHEMBL1806327

CCOC(=O)c1n[nH]c(-c2ncccc2C)c1C=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
POLB P06746 2/20 0.43
BRD4 O60885 1/20 0.43
TDP2 O95551 4/20 0.42
CYP3A4 P08684 2/20 0.39
USP2 O75604 1/20 0.39
MAPT P10636 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PDE4A P27815 1/20 0.36
CASP1 P29466 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PDE4D Q08499 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1807976 0.89 MAPT (0.43) KDM4EPOLBBRD4TDP2MAPT
SCHEMBL1803979 0.89 TDP2 (0.43) KDM4EPOLBBRD4TDP2CYP3A4
SCHEMBL1806255 0.85 METAP2 (0.38) KDM4ECYP3A4MAPTCYP1A2ALDH1A1
SCHEMBL1806148 0.76 KDM4E (0.46) KDM4EPOLBMAPTCYP1A2SMN1; SMN2
SCHEMBL1809016 0.75 KDM4E (0.48) KDM4EPOLBTDP2MAPTSMN1; SMN2
SCHEMBL14263014 0.73 ALDH1A1 (0.51) KDM4EPOLBCYP3A4MAPTCYP1A2
SCHEMBL10916488 0.72 TDP2 (0.43) KDM4EPOLBBRD4TDP2SMN1; SMN2
SCHEMBL17918923 0.72 TDP2 (0.64) POLBTDP2
SCHEMBL1807009 0.72 PDE4D (0.48) KDM4EPOLBBRD4TDP2MAPT
SCHEMBL108857 0.72 BRD4 (0.63) KDM4EPOLBBRD4TDP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501703-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060035-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed